Medication info
Linadime Tablet 5 mg (Linagliptin)

Linadime Tablet 5 mg (Linagliptin)

Prescription medicationTablet
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Donghwa Pharmaceutical Co., Ltd.
Appearance
Light pink round film-coated tablet
Packaging
28 tablets (14 tablets/PTP × 2), 30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201901206 · Approved 2019.02.26 · Insurance code 642707520

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this drug is 5 mg once daily. It may be administered with or without food. When administered in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and insulin secretagogue may be necessary to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Donghwa Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Abnormal blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes, when combined with dietary and exercise therapies. It can be used as a monotherapy or in combination with other medications to enhance blood sugar control. Therefore, it is used in ways that are appropriate for the patient's health condition to aid in blood sugar management.

Dosage and Administration

Adult dosage

The recommended dose of this drug is 5 mg once daily. It may be administered with or without food. When administered in combination with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and insulin secretagogue may be necessary to minimize the risk of hypoglycemia.

Precautions

This medication should not be used by individuals with allergies to the active ingredient or other components. Additionally, it should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is required when using this medication, particularly if taken in conjunction with insulin or sulfonylureas, which may induce hypoglycemia. The risk of hypoglycemia may increase when used with these medications, hence dosage adjustments may be necessary. Experience with this medication in patients with heart failure is limited; therefore, careful administration is warranted. If severe abdominal pain, indicative of acute pancreatitis, occurs while taking this medication, it should be discontinued immediately, and medical advice should be sought. A skin condition called bullous pemphigoid may occur, so any skin blisters or lesions should be reported to a doctor immediately. In such cases, medication should be stopped and specialized medical attention should be sought. Hypoglycemic symptoms may occur while taking this medication. If symptoms such as dizziness, cold sweat, or severe fatigue are experienced, immediate action should be taken. Women who are pregnant or breastfeeding should avoid using this medication as its safety has not been adequately confirmed. This medication is not recommended for children under 10 years of age as its safety and efficacy have not been established. Its use in children and adolescents over 10 years of age is permitted but limited. Elderly patients may use it without special dosage adjustments, but patients with impaired renal or liver function should also use it without separate dosage adjustments. In case of overdose, no specific antidote exists, so unabsorbed medication should be removed, and symptoms should be monitored closely along with necessary treatment. This medication should not be transferred to other containers, and it should be kept out of reach of children.

Side effects

  • Hypoglycemia
  • nasopharyngitis
  • hypersensitivity
  • angioedema
  • urticaria
  • hypertriglyceridemia
  • hyperlipidemia
  • cough
  • pancreatitis
  • constipation
Show 106 more
  • oral ulcer formation
  • rash
  • vesicular pemphigoid-like lesions
  • severe and disabling arthralgia
  • rhabdomyolysis
  • weight gain
  • increased lipase
  • increased amylase
  • dyspepsia
  • edema
  • facial edema
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • upper abdominal pain
  • small bowel and colon inflammation
  • bowel obstruction
  • gastroenteritis
  • shingles
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronal inflammation
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer's disease dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • anemia
  • nausea
  • diarrhea
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • viral upper respiratory infection
  • upper respiratory infection
  • dizziness
  • sensory impairment
  • pruritus
  • insomnia
  • depression
  • hypertension
  • benign prostatic hyperplasia
  • male pattern baldness
  • hyperhidrosis
  • hair loss
  • anxiety
  • contusion
  • bone contusion
  • concussion
  • bone fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eye
  • glaucoma
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hypotension
  • flushing
  • fatty liver disease
  • cholelithiasis
  • hearing loss
  • erectile dysfunction
  • thyroid enlargement

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air or moisture, at a temperature between 1 °C and 30 °C at room temperature. This will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Light pink round film-coated tablet

Package unit

28 tablets (14 tablets/PTP × 2), 30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.